939 results on '"Mehrazin, Reza"'
Search Results
2. Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
3. Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols
4. Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis
5. Single Port Groin Lymph Node Dissection in Penile Cancer
6. Robot Assisted Intracorporeal Urinary Diversion: Orthotopic Neobladder
7. Robot-Assisted Female Organ Sparing Cystectomy
8. Single Port Robot-Assisted Radical Cystectomy: Technique and Considerations
9. Tumor Characteristics Associated With Preoperatively Detectable Tumor-Informed Circulating Tumor DNA in Patients With Renal Masses Suspicious for Renal Cell Carcinoma
10. Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy
11. Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
12. Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial Carcinoma
13. Thromboembolic Events After Robotic Radical Cystectomy: A Comparative Analysis of Extended and Limited Prophylaxis
14. Early perioperative outcomes of single-port compared to multi-port robot-assisted laparoscopic partial nephrectomy
15. Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
16. Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy
17. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Research Consortium
18. Contemporary outcomes of patients undergoing robotic-assisted radical cystectomy: A comparative analysis between intracorporeal ileal conduit and neobladder urinary diversions
19. Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group
20. Same-day discharge following minimally invasive partial and radical nephrectomy: a National Surgical Quality Improvement Program (NSQIP) analysis
21. Single-Port Robot-Assisted Radical Cystectomy
22. Complications of Robot-Assisted Radical Cystectomy
23. Infections After Adoption of Antibiogram-directed Prophylaxis and Intracorporeal Urinary Diversion for Robot-assisted Radical Cystectomy
24. The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry
25. Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
26. Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment
27. Rising Serum Uric Acid Level Is Negatively Associated with Survival in Renal Cell Carcinoma
28. Retroperitoneal Robot-assisted Partial Nephrectomy: A Systematic Review and Pooled Analysis of Comparative Outcomes
29. Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker.
30. Minimally Invasive Management of Inguinal Lymph Nodes in Penile Cancer: Recent Progress and Remaining Challenges.
31. A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)
32. MP44-08 PATIENTS WITH IMPERATIVE ROBOT-ASSISTED PARTIAL NEPHRECTOMY HAVE WORSE OUTCOMES THAN THOSE WITH ELECTIVE INDICATIONS
33. PD02-07 POSITIVE CTDNA STATUS BEFORE RADICAL CYSTECTOMY PREDICTS LYMPH NODE STATUS AND PATHOLOGICAL UPSTAGING
34. PD20-05 REAL-WORLD DATA: CALL FOR PARADIGM SHIFT TOWARDS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY—ANALYSIS OF THE ROBUUST REGISTRY
35. MP61-20 UTILITY OF CIRCULATING TUMOR DNA IN PATIENTS WITH DIFFERENT STAGES OF TESTICULAR CANCER
36. MP44-18 COMPARISON OF LATERAL FLANK APPROACH AND LOW ANTERIOR ACCESS FOR SINGLE PORT (SP) RETROPERITONEAL PARTIAL NEPHRECTOMY: AN ANALYSIS FROM THE SINGLE PORT ADVANCED RESEARCH CONSORTIUM (SPARC)
37. PD38-07 90-DAY OUTCOMES COMPARING APIXABAN TO ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER ROBOTIC-ASSISTED RADICAL CYSTECTOMY
38. DEI-02 SURVIVAL OUTCOMES BY RACE ACROSS DIFFERENT CONTINENTS FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY
39. PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS
40. MP44-16 ADOPTION OF SINGLE PORT ROBOTIC PARTIAL NEPHRECTOMY INCREASES UTILIZATION OF THE RETROPERITONEAL APPROACH: A REPORT FROM THE SINGLE-PORT ADVANCED RESEARCH CONSORTIUM
41. V08-08 THE DIFFICULT NEOBLADDER: TECHNIQUES TO MOBILIZE THE ILEUM TO THE URETHRA
42. MP44-17 COMPARISON OF OUTCOMES BETWEEN SINGLE-PORT AND MULTI-PORT ROBOTIC RADICAL NEPHRECTOMY: A REPORT OF THE SINGLE PORT ADVANCED RESEARCH CONSORTIUM (SPARC)
43. MP16-19 COMPARISON OF BCG TO GEMCITABINE/DOCETAXEL IN THE INTERMEDIATE RISK GROUP COMPOSED MOSTLY OF TAHG
44. PD20-06 COMPARATIVE ANALYSIS OF NEOADJUVANT VERSUS ADJUVANT THERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA IN THE SETTING OF CLINICAL NODE POSITIVE DISEASE: ANALYSIS OF THE ROBUUST REGISTRY
45. MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
46. PD38-01 NEGATIVE CTDNA STATUS PRIOR TO RADICAL CYSTECTOMY PREDICTS IMPROVED OUTCOMES
47. MP22-11 THROMBOEMBOLIC EVENTS AFTER ROBOTIC RADICAL CYSTECTOMY: A COMPARATIVE ANALYSIS OF EXTENDED AND LIMITED PROPHYLAXIS
48. MP38-03 PREDICTORS AND OUTCOME OF LYMPH NODE INVOLVEMENT FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY FOR PRIMARY UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)
49. PD20-04 ROBOTIC DISTAL URETERECTOMY FOR HIGH-RISK DISTAL URETERAL UROTHELIAL CARCINOMA: A RETROSPECTIVE MULTICENTER COMPARATIVE ANALYSIS (ROBUUST COLLABORATIVE ANALYSIS)
50. MP38-17 REAL-WORLD MANAGEMENT OF HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA: LEVEL OF ADHERENCE TO EAU-AUA GUIDELINES—ANALYSIS OF THE ROBUUST REGISTRY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.